EYE 2.70% 19.0¢ nova eye medical limited

EYE Summary (August 2024): Incredibly Undervalued, page-358

  1. 16,324 Posts.
    lightbulb Created with Sketch. 4380
    Cheers, I do agree as well with this. I am careful not to try and get my hopes and expectations up when the company has given guidance (better to be positively surprised than negatively), but it is looking like they are getting the scale to quickly shift into highly profitable growth before what is being predicted by both the company and the analysts who cover this company. The FY24 report this week will provide much more colour, I do look forward to receiving that and estimating the various profit figures we could expect depending on the sales generated over the course of FY25.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.